Xilio Therapeutics, Inc.
XLO·NasdaqCM
9.08+0.02 (+0.28%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close9.05
Open9.11
Day range8.989.33
52-week range6.4712.59
Off day high−2.73%
Off 52-week high−27.90%
Volume8.39K
Avg. volume (3M)18.86K
Market cap59.71M
EPS (TTM)-0.6000
Forward P/E-15.65
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding6.58M
Short interest—
Earnings dateAug 6, 2025 (est.)
Analyst target—
Profit margin—
Against its peers
Compare in full ›| XLO | XBIT | ANIX | BCTX | HURA | CVM | |
|---|---|---|---|---|---|---|
| Market cap | 59.71M | 69.82M | 98.73M | — | 121.08M | 32.19M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -15.6 | 17.6 | -9.2 | — | -3.1 | -0.3 |
| Price/book | 0.8 | 0.5 | 6.8 | — | 6.6 | 2.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −16.70% | −10.55% | −35.84% | — | −19.34% | −80.40% |
| Today | +0.28% | 0.00% | −2.07% | — | −3.06% | −5.67% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All XLO news ›Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The Manila Times WALTHAM, Mass., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer,…
From articles in the 4Search news index.
In the news
1mentions in 30 days
1with it in the headline
Positivesentiment
Mentioned with
People in the coverage
Most coverage from
-
manilatimes.net1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.